My research is based on experimental studies of patient tumor specimens and pre-clinical model systems derived from these tumors as well as cancer cell lines. I apply various technologies (e.g. functional genomics, proteomics, molecular biology) to unravel molecular mechanism of treatment resistance and to identify new biomarkers for cancer patients at high risk for treatment failure.